Brief: Aeon Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards
07/02/2025 21:10
Feb 7 (Reuters) - Aeon Biopharma Inc AEON.A :
* AEON BIOPHARMA, INC. RECEIVES NOTICE OF NON-COMPLIANCE
WITH NYSE
AMERICAN CONTINUED LISTING STANDARDS
Source text: ID:nGNX3l825z
Further company coverage: AEON.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition